We have recently observed, for the first time, that the over-expression and hyper-activation of AKA and Plk1 serine/threonine (ser-thr) kinases represents a common feature of patients with advanced SM (but not of ISM patients) [21]. The gene discussed is PLK1; the disease is systemic mastocytosis.